Sabra Health Care REIT, Inc. (SBRA) Skyrockets 3.06% Today. But Here’s The Catch

If you’re on the hunt for stocks to watch today, Sabra Health Care REIT, Inc. (NASDAQ:SBRA) is a stock to give close attention to. The company shares are trading 3.06% or 0.6 points up from last closing price of $19.58, reaching $20.18 at last check. The SBRA share price has risen in 3 of the last 5 days and is up 7.76% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on solid volume too with far more shares changing hands than in a normal session. Trading activity as of this writing strengthened by 217,484 shares, and in total 1.451 million shares valued at $29.273 million were seen changing hands compared with 1.233 million shares valued at $24.144 million recorded at the previous session. You should take into consideration that a greater volume on higher prices causes bullish signal for the market. It shows the sentiment is in an uptrend and more and more traders want to enter in the SBRA stock.

Sabra Health Care REIT, Inc. (SBRA) shares have notched a 3-month gain of about 7.76%, but has still advanced 18.81% year to date. By comparison, the stock sank -7.47% over the past 12 months, while it slipped -0.66% over the 1 month. The company’s market cap is around $3.52B, with its short interest ratio standing at 5.55%.

In the current trading session for SBRA, the stock witnessed two major price actions, it rose to a high of $20.31 and was down as much as $19.47 at one point. The high recorded is very low when compared to their 52-week high which is $15.7. The 52-week high is now at -15 distance from current price. Their recent low of $23.83 represents a 29.01% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for SBRA is $18.8, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

The stock of Sabra Health Care REIT, Inc. earned $0.74 per share in the trailing 12 months and has a P/E ratio of 27.27. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 39.79 and higher compared to the sector’s average of 19.01. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. SBRA also has P/S multiple of 6.11. This is smaller versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 10.23x.

The company recorded an interesting insider sale transaction by the VP on Mar 22, 2018. A Securities and Exchanges Commission filings show that Harold W Jr. Andrews sold a total of 600 SBRA shares that day for a sum of around $10,416. Sabra Health Care REIT, Inc. (SBRA) insiders have acquired 15,034 shares in the stock within the past three months. In total, individual insiders traded 15,034 shares in the business, which makes up 2.729% of 550,998 shares that were traded over a year. In the past 12 months, insiders have purchased 438,106 shares while the seller parted with 112,892 shares.

SBRA‘s last price was up 1.71% as compared to the average trading price of 50 days recorded at $19.84 while enlarging the period to 200 trading days, the average closing price was $19.43. At present, there are 179.96 million in the total number of common shares owned by the public and among those 177.2 million shares have been available to trade. The percentage of shares being held by the company management was 0.8% while institutions stake was 94.9%. The company has generated positive returns on equity over the last 12 months (4%). It managed to keep its gross profit margin at 91.7% over the past 12 months.

When assessing the full upside of the SBRA stock, there is another set of technicals that should be looked into and considered. Its 4.11% gain from moving average of $19.38 has brought about a positive sentiment when calculated over the last 20 days. The market has allocated a beta of 0.91 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of Sabra Health Care REIT, Inc. — 0 analysts rate the stock as a buy with another 0 rating it strong buy. There are 4 analysts who maintain a hold rating for the stock, with 2 giving it a sell rating. Analysts arrived at a 12-month price target of $20.5 on shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA), which corresponds to 1.18% upside potential than its current market price of $20.18 and implies potential despite the recent advance in the price. However, their current target price has fallen from $21.25 a month ago and is down handily from the consensus target of $21.25 a quarter ago.

In the last five years, the EPS of the company has been roughly 17.4%. Though the percentage looks encouraging, extra tailwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will increase annually by 6%. The revenue of the company has risen at an average annualized rate of about 35.8 over the last five years. The company recently recorded a drop of -17.6%, but this figure is rather unattractive.

Let’s briefly check the hedge fund interest towards SBRA stock. First Trust Advisors LP added position in the company after it grew 37.3% or 82,625 shares of its common stock. The hedge fund now owns 113,444 shares worth $2,289,300, SEC documents show. FMR LLC shored up assets in the stock as 5833475 shares have been purchased, increasing its stake by 4.5% to 6,095,981 shares which are currently valued at $123,000,000. In addition, Metropolitan Life Insurance Co NY recently reported that it now owns 113,099 shares making a total of $2,282,338 based on the recent price. This refelects a change of -0.7% in their ownership.